{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T06:57:43Z","timestamp":1779173863811,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"8","content-domain":{"domain":["europeanneuropsychopharmacology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.euroneuro.2012.08.015","type":"journal-article","created":{"date-parts":[[2012,9,7]],"date-time":"2012-09-07T06:00:56Z","timestamp":1346997656000},"page":"978-987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Insight into mechanism of in vitro insulin secretion increase induced by antipsychotic clozapine: Role of FOXA1 and mitochondrial citrate carrier"],"prefix":"10.1016","volume":"23","author":[{"given":"A.","family":"Menga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Infantino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Iacobazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Convertini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Iacobazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.euroneuro.2012.08.015_bib1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0005-2728(89)80068-4","article-title":"Identification and purification of the tricarboxylate carrier from rat liver mitochondria","volume":"977","author":"Bisaccia","year":"1989","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.euroneuro.2012.08.015_bib2","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0005-2728(90)90201-E","article-title":"Kinetic characterization of the reconstituted tricarboxylate carrier from rat liver mitochondria","volume":"1019","author":"Bisaccia","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.euroneuro.2012.08.015_bib3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1097-2765(02)00459-8","article-title":"Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4","volume":"9","author":"Cirillo","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.euroneuro.2012.08.015_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0006-3223(99)00029-3","article-title":"Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response","volume":"46","author":"Conley","year":"1999","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2012.08.015_bib5","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.bbrc.2010.11.126","article-title":"Role of FOXA and Sp1 in mitochondrial acylcarnitine carrier gene expression in different cell lines","volume":"404","author":"Convertini","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.euroneuro.2012.08.015_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2202-7-69","article-title":"Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: marked differences between various antipsychotic drugs","volume":"7","author":"Fern\u00f8","year":"2006","journal-title":"BMC Neurosci."},{"issue":"1","key":"10.1016\/j.euroneuro.2012.08.015_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00213-008-1370-x","article-title":"Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver","volume":"203","author":"Fern\u00f8","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2012.08.015_bib8","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJMra035458","article-title":"Schizophrenia","volume":"349","author":"Freedman","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2012.08.015_bib9","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1007\/s00018-006-6095-6","article-title":"The Foxa family of transcription factors in development and metabolism","volume":"63","author":"Friedman","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"issue":"8","key":"10.1016\/j.euroneuro.2012.08.015_bib10","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1210\/me.2009-0513","article-title":"Foxa1 and Foxa2 maintain the metabolic and secretory features of the mature beta-cell","volume":"24","author":"Gao","year":"2010","journal-title":"Mol. Endocrinol."},{"issue":"13","key":"10.1016\/j.euroneuro.2012.08.015_bib11","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1101\/gad.10.13.1670","article-title":"Hepatic specification of the gut endoderm in vitro: cell signaling and transcriptional control","volume":"10","author":"Gualdi","year":"1996","journal-title":"Genes Dev."},{"issue":"6","key":"10.1016\/j.euroneuro.2012.08.015_bib12","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1176\/appi.ajp.157.6.975","article-title":"Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study","volume":"157","author":"Henderson","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.euroneuro.2012.08.015_bib13","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.4088\/JCP.v66n0905","article-title":"Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study","volume":"66","author":"Henderson","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.08.015_bib14","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2337\/diabetes.49.3.424","article-title":"Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion","volume":"49","author":"Hohmeier","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.euroneuro.2012.08.015_bib15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1042\/BJ20050776","article-title":"Functional analysis of the promoter of the mitochondrial phosphate carrier human gene: identification of activator and repressor elements and their transcription factors","volume":"391","author":"Iacobazzi","year":"2005","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.euroneuro.2012.08.015_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbrc.2008.08.015","article-title":"Epigenetic mechanisms and Sp1 regulate mitochondrial citrate carrier gene expression","volume":"376","author":"Iacobazzi","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.euroneuro.2012.08.015_bib17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbrc.2009.05.030","article-title":"Role of FOXA in mitochondrial citrate carrier gene expression and insulin secretion","volume":"385","author":"Iacobazzi","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.euroneuro.2012.08.015_bib18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbrc.2009.06.003","article-title":"Transcription of the mitochondrial citrate carrier gene: identification of a silencer and its binding protein ZNF224","volume":"386","author":"Iacobazzi","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.euroneuro.2012.08.015_bib19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bbrc.2007.02.114","article-title":"Transcription of the mitochondrial citrate carrier gene: role of SREBP-1, upregulation by insulin and downregulation by PUFA","volume":"356","author":"Infantino","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.euroneuro.2012.08.015_bib20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1042\/BJ20111275","article-title":"The mitochondrial citrate carrier: a new player in inflammation","volume":"438","author":"Infantino","year":"2011","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.euroneuro.2012.08.015_bib21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bbrc.2011.07.047","article-title":"Identification of a novel Sp1 splice variant as a strong transcriptional activator","volume":"412","author":"Infantino","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.euroneuro.2012.08.015_bib22","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ymgme.2010.11.166","article-title":"Impairment of methyl cycle affects mitochondrial methyl availability and glutathione level in Down's syndrome","volume":"102","author":"Infantino","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.euroneuro.2012.08.015_bib23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.schres.2004.03.024","article-title":"Atypical antipsychotics and glucose dysregulation: a systematic review","volume":"71","author":"Jin","year":"2004","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.euroneuro.2012.08.015_bib24","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.2337\/diabetes.54.5.1552","article-title":"Inhibitory effects of antipsychotics on carbachol-enhanced insulin secretion from perifused rat islets: role of muscarinic antagonism in antipsychotic-induced diabetes and hyperglycemia","volume":"54","author":"Johnson","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.euroneuro.2012.08.015_bib25","doi-asserted-by":"crossref","first-page":"35624","DOI":"10.1074\/jbc.M602606200","article-title":"The mitochondrial citrate\/isocitrate carrier plays a regulatory role in glucose-stimulated insulin secretion","volume":"281","author":"Joseph","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.euroneuro.2012.08.015_bib26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s002320010046","article-title":"Structure and function of mitochondrial anion transport proteins","volume":"179","author":"Kaplan","year":"2001","journal-title":"J. Membr. Biol."},{"issue":"4","key":"10.1016\/j.euroneuro.2012.08.015_bib27","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1192\/bjp.bp.109.076935","article-title":"Treatment with antipsychotics and the risk of diabetes in clinical practice","volume":"197","author":"Kessing","year":"2010","journal-title":"Br. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.euroneuro.2012.08.015_bib28","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0002-9343(01)01000-2","article-title":"Clozapine-associated diabetes","volume":"111","author":"Koller","year":"2001","journal-title":"Am. J. Med."},{"key":"10.1016\/j.euroneuro.2012.08.015_bib29","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.cell.2008.01.018","article-title":"FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription","volume":"132","author":"Lupien","year":"2008","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.euroneuro.2012.08.015_bib30","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4088\/JCP.v60n1112","article-title":"Different influences of classical antipsychotics and clozapine on glucose\u2013insulin homeostasis in patients with schizophrenia or related psychoses","volume":"60","author":"Melkersson","year":"1999","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2012.08.015_bib32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0924-977X(03)00072-5","article-title":"Clozapine and olanzapine, but not conventional antipsychotics, increase insulin release in vitro","volume":"14","author":"Melkersson","year":"2004","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.euroneuro.2012.08.015_bib33","first-page":"854","article-title":"Effects of the atypical antipsychotic clozapine on insulin release in vitro","volume":"28","author":"Melkersson","year":"2007","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.euroneuro.2012.08.015_bib34","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1210\/en.2003-1099","article-title":"Glucose sensitivity and metabolism\u2013secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells","volume":"145","author":"Merglen","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.euroneuro.2012.08.015_bib35","series-title":"Diabetes Mellitus","first-page":"513","article-title":"Insulin resistance","author":"Olefsky","year":"1997"},{"key":"10.1016\/j.euroneuro.2012.08.015_bib36","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00424-003-1099-7","article-title":"The mitochondrial transporter family (SLC25): physiological and pathological implications","volume":"447","author":"Palmieri","year":"2004","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.euroneuro.2012.08.015_bib37","article-title":"The mitochondrial transporter family SLC25: identification, properties and physiopathology","author":"Palmieri","year":"2012","journal-title":"Mol. Aspects Med."},{"issue":"1","key":"10.1016\/j.euroneuro.2012.08.015_bib38","first-page":"69","article-title":"Hepatocyte nuclear factor-3 alpha promoter regulation involves recognition by cell-specific factors, thyroid transcription factor-1, and auto activation","volume":"8","author":"Peterson","year":"1997","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.euroneuro.2012.08.015_bib39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11010-006-9160-4","article-title":"SREBP activation by antipsychotic- and antidepressant-drugs in cultured human liver cells: relevance for metabolic side-effects?","volume":"289","author":"Raeder","year":"2006","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.euroneuro.2012.08.015_bib40","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/00044011-199918020-00002","article-title":"Effect of clozapine\u2013quetiapine combination therapy on weight and glycemic control","volume":"18","author":"Reinstein","year":"1999","journal-title":"Clin. Drug Invest."},{"issue":"12","key":"10.1016\/j.euroneuro.2012.08.015_bib41","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1007\/s00125-006-0446-6","article-title":"The atypical antipsychotic clozapine impairs insulin secretion by inhibiting glucose metabolism and distal steps in rat pancreatic islets","volume":"49","author":"Sasaki","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.euroneuro.2012.08.015_bib42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.diabet.2007.01.003","article-title":"Abnormal glucose metabolism in patients treated with antipsychotics","volume":"33","author":"Scheen","year":"2007","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.euroneuro.2012.08.015_bib43","doi-asserted-by":"crossref","first-page":"42812","DOI":"10.1074\/jbc.M106344200","article-title":"Foxa3 (hepatocyte nuclear factor 3 gamma) is required for the regulation of hepatic GLUT2 expression and the maintenance of glucose homeostasis during a prolonged fast","volume":"276","author":"Shen","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.euroneuro.2012.08.015_bib44","doi-asserted-by":"crossref","first-page":"10152","DOI":"10.1073\/pnas.96.18.10152","article-title":"Impaired glucose homeostasis and neonatal mortality in hepatocyte nuclear factor 3alpha-deficient mice","volume":"96","author":"Shih","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl. B","key":"10.1016\/j.euroneuro.2012.08.015_bib45","first-page":"157","article-title":"Clozapine and weight gain","volume":"55","author":"Umbricht","year":"1994","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.08.015_bib46","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.2337\/db05-0470","article-title":"Foxa1-deficient mice exhibit impaired insulin secretion due to uncoupled oxidative phosphorylation","volume":"55","author":"Vatamaniuk","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.euroneuro.2012.08.015_bib47","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/sj.npp.1301142","article-title":"Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis","volume":"32","author":"Vestri","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2012.08.015_bib48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2210-9-10","article-title":"Psychotropic drugs upregulate the expression of cholesterol transport proteins including ApoE in cultured human CNS- and liver cells","volume":"9","author":"Vik-Mo","year":"2009","journal-title":"BMC Pharmacol."},{"issue":"7020","key":"10.1016\/j.euroneuro.2012.08.015_bib49","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature03047","article-title":"Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes","volume":"432","author":"Wolfrum","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2012.08.015_bib50","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-0029-1212019","article-title":"The effect of clozapine on glucose metabolism","volume":"106","author":"Yazici","year":"1998","journal-title":"Exp. Clin. Endocrinol. Diabetes"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X12002465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X12002465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T19:54:32Z","timestamp":1542743672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X12002465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0924977X12002465"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2012.08.015","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insight into mechanism of in vitro insulin secretion increase induced by antipsychotic clozapine: Role of FOXA1 and mitochondrial citrate carrier","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2012.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}